Ergawealth Advisors’s AbbVie ABBV Stock Holding History

Ergawealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11M	Buy	5,116 +102	+2%	+$22.6K	0.49%	23
2025 Q4	$1.15M	Hold	5,014	–	–	0.53%	20
2025 Q3	$1.16M	Buy	5,014 +52	+1%	+$10.6K	0.54%	25
2025 Q2	$921K	Buy	4,962 +106	+2%	+$19.7K	0.41%	30
2025 Q1	$1.02M	Sell	4,856 -100	-2%	-$19.4K	0.5%	26
2024 Q4	$881K	Hold	4,956	–	–	0.44%	26
2024 Q3	$979K	Sell	4,956 -36	-0.7%	-$6.72K	0.49%	25
2024 Q2	$856K	Sell	4,992 -1,954	-28%	-$324K	0.47%	27
2024 Q1	$1.26M	Buy	6,946 +2,091	+43%	+$360K	0.69%	19
2023 Q4	$752K	Hold	4,855	–	–	0.46%	22
2023 Q3	$724K	Hold	4,855	–	–	0.5%	19
2023 Q2	$654K	Buy	4,855 +1	+0%	+$147	0.45%	19
2023 Q1	$774K	Hold	4,854	–	–	0.63%	20
2022 Q4	$784K	Buy	+4,854	New	+$744K	0.71%	20

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ergawealth Advisors's ABBV Position: Q1 2026 in Review

Ergawealth Advisors increased its AbbVie (ABBV) stake by 2% in Q1 2026, buying an estimated $22.6K and bringing the position to 5,116 shares worth $1.11M. The position accounts for 0.49% of the portfolio, ranked #23.

Ergawealth Advisors first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.26M in Q1 2024. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Ergawealth Advisors held 5,116 shares of AbbVie worth $1.11M as of Q1 2026.
Ergawealth Advisors bought 102 AbbVie shares in Q1 2026, an estimated $22.6K.
AbbVie made up 0.49% of Ergawealth Advisors's portfolio in Q1 2026, its #23 holding.
Ergawealth Advisors first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Ergawealth Advisors's AbbVie position peaked at $1.26M in Q1 2024.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Ergawealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.